Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study

References

• Global Initiative for Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. Global Initiative for Obstructive Lung Disease; 2022.
   Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update. Transl Respir Med. 2014;23. doi:10.1186/2213-0802-2-3
   Google Scholar
• Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27(6):414–418. doi:10.1089/jamp.2014.1132
   PubMed Web of Science ®Google Scholar
• Lavorini F, Fontana GA, Usmani OS. New inhaler devices - the good, the bad and the ugly. Respiration. 2014;88(1):3–15. doi:10.1159/000363390
   PubMed Web of Science ®Google Scholar
• Liang CY, Chen YJ, Sheu SM, et al. Misuse of inhalers among COPD patients in a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2018:131309–131316. doi:10.2147/COPD.S158864
   Web of Science ®Google Scholar
• Molimard M, Raherison C, Lignot S, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2). doi:10.1183/13993003.01794-2016
   PubMed Web of Science ®Google Scholar
• Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19(1):10. doi:10.1186/s12931-017-0710-y
   PubMed Web of Science ®Google Scholar
• Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9(1):60. doi:10.1186/2049-6958-9-60
   PubMedGoogle Scholar
• Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(10):1333–1343. doi:10.1164/rccm.201604-0733OC
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN, Lavorini F, Usmani OS. Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat((R)) or HandiHaler((R)). Patient Prefer Adherence. 2016;101561–101572. doi:10.2147/PPA.S82857
   Web of Science ®Google Scholar
• Kaplan A, Price D. Matching inhaler devices with patients: the role of the primary care physician. Can Respir J. 2018;2018:9473051. doi:10.1155/2018/9473051
   PubMed Web of Science ®Google Scholar
• Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4381–4390. doi:10.2147/copd.s3391
   Google Scholar
• Chorao P, Pereira AM, Fonseca JA. Inhaler devices in asthma and COPD – an assessment of inhaler technique and patient preferences. Respir Med. 2014;108(7):968–975. doi:10.1016/j.rmed.2014.04.019
   PubMed Web of Science ®Google Scholar
• Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28(3):219–228. doi:10.1089/jamp.2014.1142
   PubMed Web of Science ®Google Scholar
• Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–577. doi:10.1164/rccm.200906-0907OC
   PubMed Web of Science ®Google Scholar
• Inhaler Error Steering C, Price D. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107(1):37–46. doi:10.1016/j.rmed.2012.09.017
   PubMed Web of Science ®Google Scholar
• Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. BMJ. 2010:341c5146. doi:10.1136/bmj.c5146
   Web of Science ®Google Scholar
• Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. doi:10.1007/s11606-012-2077-6
   PubMed Web of Science ®Google Scholar
• Ding B, Small M, Scheffel G, et al. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018:13927–13936. doi:10.2147/COPD.S154525
   Web of Science ®Google Scholar
• Gregoriano C, Dieterle T, Breitenstein AL, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237. doi:10.1186/s12931-018-0936-3
   PubMed Web of Science ®Google Scholar
• Price D, Keininger DL, Viswanad B, et al. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Int J Chron Obstruct Pulmon Dis. 2018:13695–13702. doi:10.2147/COPD.S149404
   Web of Science ®Google Scholar
• Bjermer L. The importance of continuity in inhaler device choice for asthma and chronic obstructive pulmonary disease. Respiration. 2014;88(4):346–352. doi:10.1159/000363771
   PubMed Web of Science ®Google Scholar
• Cheng SL. Comparison of effectiveness using different dual bronchodilator agents in chronic obstructive pulmonary disease treatment. J Clin Med. 2021;10(12). doi:10.3390/jcm10122649
   Web of Science ®Google Scholar
• Takaku Y, Kurashima K, Ohta C, et al. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease? Respir Med. 2017:123110–123115. doi:10.1016/j.rmed.2016.12.012
   Web of Science ®Google Scholar
• Dudvarski Ilic A, Zugic V, Zvezdin B, et al. Influence of inhaler technique on asthma and COPD control: a multicenter experience. Int J Chron Obstruct Pulmon Dis. 2016:112509–112517. doi:10.2147/COPD.S114576
   Web of Science ®Google Scholar
• Slade D, Ray R, Moretz C, et al. Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study. BMC Pulm Med. 2021;21(1):253. doi:10.1186/s12890-021-01612-5
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Montero-Caballero J, Richard F, et al. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Int J Chron Obstruct Pulmon Dis. 2016:11407–11415. doi:10.2147/COPD.S91118
   Web of Science ®Google Scholar
• Zervas E, Samitas K, Gaga M. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. Int J Chron Obstruct Pulmon Dis. 2016;111845–111855. doi:10.2147/COPD.S113870
   Web of Science ®Google Scholar
• Feldman GJ, Sousa AR, Lipson DA, et al. Comparative efficacy of once-daily umeclidinium/vilanterol and tiotropium/olodaterol therapy in symptomatic chronic obstructive pulmonary disease: a randomized study. Adv Ther. 2017;34(11):2518–2533. doi:10.1007/s12325-017-0626-4
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Fabbri LM, Ferguson GT, et al. Baseline symptom score impact on benefits of glycopyrrolate/formoterol metered dose inhaler in COPD. Chest. 2017;152(6):1169–1178. doi:10.1016/j.chest.2017.07.007
   PubMed Web of Science ®Google Scholar
• Han MK, Ray R, Foo J, et al. Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD. NPJ Prim Care Respir Med. 2018;28(1):32. doi:10.1038/s41533-018-0099-1
   PubMed Web of Science ®Google Scholar
• Oba Y, Keeney E, Ghatehorde N, et al. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2018:12CD012620. doi:10.1002/14651858.CD012620.pub2
   Web of Science ®Google Scholar
• Chen SY, Huang CK, Peng HC, et al. Inappropriate peak inspiratory flow rate with dry powder inhaler in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):7271. doi:10.1038/s41598-020-64235-6
   PubMed Web of Science ®Google Scholar